Recent Updates
Recently added Catalysts
CELU Positive Sentiment

Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States

Thursday, October 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celularity Inc. and Vesalius Longevity Labs have announced an exclusive collaboration to create a U.S.-based manufacturing platform for Peptual-branded active pharmaceutical ingredients. This partnership aims to enhance the production of peptide APIs, emphasizing their commitment to longevity and regenerative medicine. This initiative marks a significant step in the biopharma sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Exclusive collaboration between Celularity and Vesalius
  • Establishment of U.S. manufacturing platform
  • Focus on longevity and regenerative medicine

Full Press Release Details

FLORHAM PARK, N.J. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, and Vesalius Longevity Labs Inc. (“Vesalius”), a leading, global peptide and longevity brand, today announced that they have entered into an exclusive manufacturing agreement to establish a dedicated, first-of-its-kind, U.S. final stage API manufacturing and supply platform for Vesalius’s Peptual-branded active pharmaceutical ing

Frequently Asked Questions

What is the collaboration between Celularity and Vesalius?

Celularity and Vesalius have signed an exclusive agreement for peptide API manufacturing.

Where will the Peptual peptide APIs be manufactured?

The Peptual peptide APIs will be manufactured in the United States.

What is the focus of this collaboration?

The collaboration focuses on longevity and regenerative medicine.

What is Peptual?

Peptual is a brand of active pharmaceutical ingredients developed by Vesalius.

ShareAdd on Google
Tags: CELU Celularity Vesalius peptide APIs regenerative medicine longevity
Last updated: Oct 29, 2026

Biotech snapshot

Cash runway
$1M liquidity · $0M/mo burn
~2 mo
High dilution risk